Viewing Study NCT01091051


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-01-05 @ 5:45 PM
Study NCT ID: NCT01091051
Status: TERMINATED
Last Update Posted: 2013-06-11
First Post: 2010-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis
Sponsor: Innovaderm Research Inc.
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: Inno-6012
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View